• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝移植术后耐碳青霉烯类肺炎克雷伯菌感染的危险因素:定植在移植前后的重要性。

Risk factors for infection with carbapenem-resistant Klebsiella pneumoniae after liver transplantation: the importance of pre- and posttransplant colonization.

机构信息

Infectious Diseases Unit, Department of Medical and Surgical Sciences, Sant'Orsola Hospital, Alma Mater University of Bologna, Bologna, Italy.

Internal Medicine Unit for the Treatment of Severe Organ Failure, Department of Medical and Surgical Sciences, Sant'Orsola Hospital, Alma Mater Studiorum University of Bologna, Bologna, Italy.

出版信息

Am J Transplant. 2015 Jun;15(6):1708-15. doi: 10.1111/ajt.13136. Epub 2015 Mar 4.

DOI:10.1111/ajt.13136
PMID:25754742
Abstract

Improved understanding of risk factors associated with carbapenem-resistant-Klebsiella pneumoniae (CR-KP) infection after liver transplantation (LT) can aid development of effective preventive strategies. We performed a prospective cohort study of all adult patients undergoing LT at our hospital during 30-month period to define risk factors associated with CR-KP infection. All patients were screened for CR-KP carriage by rectal swabs before and after LT. No therapy was administered to decolonize or treat asymptomatic CR-KP carriers. All patients were monitored up to 180 days after LT. Of 237 transplant patients screened, 41 were identified as CR-KP carriers (11 at LT, 30 after LT), and 20 developed CR-KP infection (18 bloodstream-infection, 2 pneumonia) a median of 41.5 days after LT. CR-KP infection rates among patients non-colonized, colonized at LT, and colonized after LT were 2%, 18.2% and 46.7% (p < 0.001). Independent risk factors for CR-KP infection identified by multivariate analysis, included: renal-replacement-therapy; mechanical ventilation > 48 h; HCV recurrence, and colonization at any time with CR-KP. Based on these four variables, we developed a risk score that effectively discriminated patients at low versus higher risk for CR-KP infection (AUC 0.93, 95% CI 0.86-1.00, p < 0.001). Our results may help to design preventive strategies for LT recipients in CR-KP endemic areas.

摘要

对肝移植(LT)后与碳青霉烯类耐药肺炎克雷伯菌(CR-KP)感染相关的危险因素的深入了解,可以帮助制定有效的预防策略。我们对我院在 30 个月期间接受 LT 的所有成年患者进行了前瞻性队列研究,以确定与 CR-KP 感染相关的危险因素。所有患者在 LT 前后均通过直肠拭子筛查 CR-KP 定植情况。对无症状的 CR-KP 携带者不进行去定植或治疗。所有患者均在 LT 后 180 天内进行监测。在筛查的 237 名移植患者中,有 41 名被确定为 CR-KP 携带者(LT 时 11 名,LT 后 30 名),有 20 名患者发生 CR-KP 感染(18 名血流感染,2 名肺炎),LT 后中位时间为 41.5 天。未定植、LT 时定植和 LT 后定植的患者中,CR-KP 感染率分别为 2%、18.2%和 46.7%(p<0.001)。多变量分析确定的 CR-KP 感染的独立危险因素包括:肾脏替代治疗;机械通气>48 小时;HCV 复发以及任何时间 CR-KP 定植。基于这四个变量,我们开发了一个风险评分,可以有效地区分 LT 患者的低危与高危 CR-KP 感染(AUC 0.93,95%CI 0.86-1.00,p<0.001)。我们的研究结果可能有助于在 CR-KP 流行地区为 LT 受者制定预防策略。

相似文献

1
Risk factors for infection with carbapenem-resistant Klebsiella pneumoniae after liver transplantation: the importance of pre- and posttransplant colonization.肝移植术后耐碳青霉烯类肺炎克雷伯菌感染的危险因素:定植在移植前后的重要性。
Am J Transplant. 2015 Jun;15(6):1708-15. doi: 10.1111/ajt.13136. Epub 2015 Mar 4.
2
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study.直肠定植携带碳青霉烯类耐药肺炎克雷伯菌血流感染的危险因素:一项前瞻性观察性多中心研究。
Clin Microbiol Infect. 2014 Dec;20(12):1357-62. doi: 10.1111/1469-0691.12747. Epub 2014 Aug 11.
3
Impact of carbapenem-resistant Klebsiella pneumoniae (CR-KP) infections in kidney transplantation.耐碳青霉烯类肺炎克雷伯菌(CR-KP)感染对肾移植的影响。
Transpl Infect Dis. 2017 Dec;19(6). doi: 10.1111/tid.12757. Epub 2017 Sep 28.
4
Epidemiology, management, and outcome of carbapenem-resistant Klebsiella pneumoniae bloodstream infections in hospitals within the same endemic metropolitan area.同一流行都市地区医院内耐碳青霉烯类肺炎克雷伯菌血流感染的流行病学、管理和结局。
J Infect Public Health. 2018 Mar-Apr;11(2):171-177. doi: 10.1016/j.jiph.2017.06.003. Epub 2017 Jun 28.
5
Risk factors for infections due to carbapenem-resistant Klebsiella pneumoniae after open heart surgery.心脏直视手术后耐碳青霉烯类肺炎克雷伯菌感染的危险因素
Interact Cardiovasc Thorac Surg. 2016 Nov;23(5):762-768. doi: 10.1093/icvts/ivw228. Epub 2016 Jul 1.
6
Patient risk factors for outer membrane permeability and KPC-producing carbapenem-resistant Klebsiella pneumoniae isolation: results of a double case-control study.患者发生外膜通透性改变和产 KPC 碳青霉烯类耐药肺炎克雷伯菌分离的危险因素:一项双病例对照研究结果。
Infection. 2013 Feb;41(1):61-7. doi: 10.1007/s15010-012-0354-2. Epub 2012 Oct 16.
7
Impact of Two Antibiotic Therapies on Clinical Outcome and Gut Microbiota Profile in Liver Transplant Paediatric Candidates Colonized by Carbapenem-Resistant CR-KP.两种抗生素治疗方案对定植碳青霉烯类耐药肠杆菌科细菌的肝移植候选儿童临床结局和肠道微生物组的影响。
Front Cell Infect Microbiol. 2021 Dec 14;11:730904. doi: 10.3389/fcimb.2021.730904. eCollection 2021.
8
Mortality associated with carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients.肝移植受者中耐碳青霉烯类肺炎克雷伯菌感染相关的死亡率。
Liver Transpl. 2012 Apr;18(4):468-74. doi: 10.1002/lt.23374.
9
Liver Transplantation and Gut Microbiota Profiling in a Child Colonized by a Multi-Drug Resistant : A New Approach to Move from Antibiotic to "Eubiotic" Control of Microbial Resistance.肝移植和肠道微生物组分析在一个被多药耐药菌定植的儿童中:从抗生素到“生态友好型”控制微生物耐药的新方法。
Int J Mol Sci. 2018 Apr 25;19(5):1280. doi: 10.3390/ijms19051280.
10
Risk factors for recurrent carbapenem resistant Klebsiella pneumoniae bloodstream infection: a prospective cohort study.复发性耐碳青霉烯类肺炎克雷伯菌血流感染的危险因素:一项前瞻性队列研究。
Eur J Clin Microbiol Infect Dis. 2017 Oct;36(10):1965-1970. doi: 10.1007/s10096-017-3020-x. Epub 2017 Jun 1.

引用本文的文献

1
Silent Carriers, Severe Consequences: The Hidden Threat of Carbapenem-Resistant Enterobacteriaceae Colonization in Liver Transplantation.沉默的携带者,严重的后果:肝移植中耐碳青霉烯类肠杆菌科细菌定植的潜在威胁
J Clin Exp Hepatol. 2025 Jul-Aug;15(4):102600. doi: 10.1016/j.jceh.2025.102600. Epub 2025 May 24.
2
The Challenge of Bacterial Infections During Intensive Care Unit Stay After Heart Transplantation.心脏移植后重症监护病房住院期间细菌感染的挑战
Transpl Infect Dis. 2025 Apr 20;27(3):e70031. doi: 10.1111/tid.70031.
3
Carbapenem-resistant infections after liver transplantation: Drug resistance, risk factors and impact on prognosis.
肝移植术后耐碳青霉烯类感染:耐药性、危险因素及对预后的影响
World J Gastroenterol. 2025 Feb 28;31(8):98415. doi: 10.3748/wjg.v31.i8.98415.
4
Outcomes of Living Donor Liver Transplantation in Recipients Colonized With Carbapenem-Resistant Enterobacterales.耐碳青霉烯肠杆菌定植受者活体肝移植的结局
J Clin Exp Hepatol. 2025 Jul-Aug;15(4):102508. doi: 10.1016/j.jceh.2025.102508. Epub 2025 Jan 25.
5
Risk factors for bloodstream infections due to carbapenem-resistant Enterobacterales: a nested case-control-control study.碳青霉烯类耐药肠杆菌科血流感染的危险因素:一项巢式病例对照对照研究。
J Antimicrob Chemother. 2024 Sep 3;79(9):2132-2141. doi: 10.1093/jac/dkae157.
6
Multidrug-resistant bacterial infections in the liver transplant setting.肝移植患者中的多重耐药菌感染。
Updates Surg. 2024 Nov;76(7):2521-2529. doi: 10.1007/s13304-024-01903-6. Epub 2024 Jun 25.
7
Long-term outcomes and risk factors for early bacterial infection after pediatric liver transplantation: a prospective cohort study.儿童肝移植后早期细菌感染的长期结局和危险因素:一项前瞻性队列研究。
Int J Surg. 2024 Sep 1;110(9):5452-5462. doi: 10.1097/JS9.0000000000001670.
8
infections after liver transplantation: Drug resistance and distribution of pathogens, risk factors, and influence on outcomes.肝移植术后感染:病原体的耐药性与分布、危险因素及对预后的影响
World J Hepatol. 2024 Apr 27;16(4):612-624. doi: 10.4254/wjh.v16.i4.612.
9
Gut microbiome dynamics and Enterobacterales infection in liver transplant recipients: A prospective observational study.肝移植受者的肠道微生物群动态变化与肠杆菌科感染:一项前瞻性观察研究。
JHEP Rep. 2024 Feb 12;6(4):101039. doi: 10.1016/j.jhepr.2024.101039. eCollection 2024 Apr.
10
A comprehensive evaluation of risk factors for mortality, infection and colonization associated with CRGNB in adult solid organ transplant recipients: a systematic review and meta-analysis.成人实体器官移植受者中与 CRGNB 相关的死亡率、感染和定植的危险因素的综合评估:系统评价和荟萃分析。
Ann Med. 2024 Dec;56(1):2314236. doi: 10.1080/07853890.2024.2314236. Epub 2024 Mar 5.